Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

Dorsal root ganglion RFA is used to treat radiculopathy. There are multiple applications of pulsed RFA in the treatment of chronic pain.

I last wrote here several months ago about the sodium channel (NaV1.8) inhibitor VX-548 (now known as suzetrigine), which is ...

The company tested suzetrigine in a Phase 2 study in patients with painful lumbrosacral radiculopathy ... set of cystic fibrosis drugs, is hoping the non-opioid pain pill can be its next chapter.

The Boston drugmaker released results on Thursday showing that the drug, suzetrigine, reduced pain compared to baseline in people with lumbosacral radiculopathy, a form of chronic pain caused by ...

The following is a summary of “Are Stabilisation Exercises Effective After Epidural Steroid Injection in Patients With ...

Vertex Pharmaceuticals shares sank Thursday after the company reported mixed results in a Phase 2 drug trial to treat ...

highly selective NaV1.8 pain signal inhibitor in people with painful lumbosacral radiculopathy, or LSR. The study met its primary endpoint with statistically significant and clinically meaningful ...

About the Phase 2 Suzetrigine Lumbosacral Radiculopathy (LSR ... under priority review by the FDA for the treatment of moderate-to-severe acute pain with a Prescription Drug User Fee Act (PDUFA ...

We connected with some experts to learn how to sleep with sciatica pain. Here are their top tips. “Sciatica is a frequently used term for lumbar radiculopathy ... These drugs “can be ...

Dorsal root ganglion RFA is used to treat radiculopathy. There are multiple applications of pulsed RFA in the treatment of chronic pain.